Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study

dc.contributor.author
Cárdenas, Andrés
dc.contributor.author
Solà, Elsa
dc.contributor.author
Rodríguez Gullello, Ezequiel Alejandro
dc.contributor.author
Barreto, Rogelio
dc.contributor.author
Graupera, Isabel
dc.contributor.author
Pavesi, Marco
dc.contributor.author
Saliba, Faouzi
dc.contributor.author
Welzel, Tania Mara
dc.contributor.author
Martínez González, Javier
dc.contributor.author
Gustot, Thierry
dc.contributor.author
Bernardi, Mauro
dc.contributor.author
Arroyo, Vicente
dc.contributor.author
Ginès i Gibert, Pere
dc.date.issued
2018-03-13T17:34:21Z
dc.date.issued
2018-03-13T17:34:21Z
dc.date.issued
2014-12-13
dc.date.issued
2018-03-13T17:34:21Z
dc.identifier
1364-8535
dc.identifier
https://hdl.handle.net/2445/120686
dc.identifier
649508
dc.identifier
25643318
dc.description.abstract
INTRODUCTION: Hyponatremia is a marker of poor prognosis in patients with cirrhosis. This analysis aimed to assess if hyponatremia also has prognostic value in patients with acute-on-chronic liver failure (ACLF), a syndrome characterized by acute decompensation of cirrhosis, organ failure(s) and high short-term mortality. METHODS: We performed an analysis of the Chronic Liver Failure Consortium CANONIC database in 1,341 consecutive patients admitted to 29 European centers with acute decompensation of cirrhosis (including ascites, gastrointestinal bleeding, hepatic encephalopathy, or bacterial infections, or any combination of these), both with and without associated ACLF (301 and 1,040 respectively). RESULTS: Of the 301 patients with ACLF, 24.3% had hyponatremia at inclusion compared to 12.3% of 1,040 patients without ACLF (P <0.001). Model for end-stage liver disease, Child-Pugh and chronic liver failure-SOFA scores were significantly higher in patients with ACLF and hyponatremia compared to those without hyponatremia. The presence of hyponatremia (at inclusion or during hospitalization) was a predictive factor of survival both in patients with and without ACLF. The presence of hyponatremia and ACLF was found to have an independent effect on 90-day survival after adjusting for the potential confounders. Hyponatremia in non-ACLF patients nearly doubled the risk (hazard ratio (HR) 1.81 (1.33 to 2.47)) of dying at 90 days. However, when considering patients with both factors (ACLF and hyponatremia) the relative risk of dying at 90 days was significantly higher (HR 6.85 (3.85 to 12.19) than for patients without both factors. Patients with hyponatremia and ACLF had a three-month transplant-free survival of only 35.8% compared to 58.7% in those with ACLF without hyponatremia (P <0.001). CONCLUSIONS: The presence of hyponatremia is an independent predictive factor of survival in patients with ACLF. In cirrhosis, outcome of patients with ACLF is dependent on its association with hyponatremia.
dc.format
8 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13054-014-0700-0
dc.relation
Critical Care, 2014, vol. 18, num. 6, p. 700
dc.relation
https://doi.org/10.1186/s13054-014-0700-0
dc.rights
cc-by (c) Cárdenas, Andrés et al., 2014
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Malalties del fetge
dc.subject
Insuficiència hepàtica
dc.subject
Medicina interna
dc.subject
Liver diseases
dc.subject
Liver failure
dc.subject
Internal medicine
dc.title
Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)